EKF Diagnostics Holdings plc (LON:EKF – Get Free Report) shares traded up 0.4% on Wednesday. The company traded as high as GBX 24.64 and last traded at GBX 24.50. Approximately 108,105 shares were traded during trading, a decline of 69% from the average daily volume of 343,814 shares. The stock had previously closed at GBX 24.40.
EKF Diagnostics Price Performance
The company has a market cap of £104.85 million, a PE ratio of 42.24 and a beta of 0.51. The firm’s 50-day moving average is GBX 24.78 and its 200-day moving average is GBX 25.33. The company has a quick ratio of 1.77, a current ratio of 4.72 and a debt-to-equity ratio of 2.09.
EKF Diagnostics (LON:EKF – Get Free Report) last issued its quarterly earnings data on Tuesday, September 15th. The company reported GBX 0.54 EPS for the quarter. EKF Diagnostics had a net margin of 4.86% and a return on equity of 3.58%. On average, equities analysts anticipate that EKF Diagnostics Holdings plc will post 2.30 EPS for the current year.
About EKF Diagnostics
EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Recommended Stories
- Five stocks we like better than EKF Diagnostics
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
